Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 205

1.

Assessment of diastolic dysfunction in patients with acute coronary syndrome and preserved systolic function: comparison between Doppler transthoracic echocardiography and velocity-encoded cardiac magnetic resonance.

Azarisman SM, Shirazi M, Bradley J, Teo KS, Worthley MI, Worthley SG.

Acta Cardiol. 2016 Aug;71(4):425-34. doi: 10.2143/AC.71.4.3159695. No abstract available.

2.

Aortic atheroma burden predicts acute cerebrovascular events after transcatheter aortic valve implantation: insights from volumetric multislice computed tomography analysis.

Kataoka Y, Puri R, Pisaniello AD, Hammadah M, Qintar M, Uno K, Montarello JK, Nicholls SJ, Worthley SG.

EuroIntervention. 2016 Aug 20;12(6):783-9. doi: 10.4244/EIJV12I6A127.

3.

[OP.4C.04] SAFETY AND PERFORMANCE OF THE ENLIGHTN RENAL DENERVATION SYSTEM IN PATIENTS WITH DRUG-RESISTANT HYPERTENSION: POOLED ANALYSES FROM THE ENLIGHTN 1, 2 AND 3 TRIALS.

Lobo MD, Montarello J, Saxena M, Jain A, Walters D, Pincus M, Tsioufis C, Papademetriou V, Worthley S.

J Hypertens. 2016 Sep;34 Suppl 2:e48. doi: 10.1097/01.hjh.0000491460.20240.18.

PMID:
27508709
4.

Fungal Obstruction of Transcatheter Aortic Valve Replacement Valve.

Nelson AJ, Montarello NJ, Roberts-Thomson RL, Montarello N, Delacroix S, Chokka RG, Sidharta SL, Thomas T, Worthley SG.

Circ Cardiovasc Interv. 2016 Aug;9(8). pii: e004117. doi: 10.1161/CIRCINTERVENTIONS.116.004117. No abstract available.

PMID:
27496638
5.

Transcatheter Aortic Valve Replacement Using the Portico System: 10 Things to Remember.

Tzikas A, Amrane H, Bedogni F, Brambilla N, Kefer J, Manoharan G, Makkar R, Möllman H, Rodés-Cabau J, Schäfer U, Settergren M, Spargias K, van Boven A, Walther T, Worthley SG, Sondergaard L.

J Interv Cardiol. 2016 Aug 5. doi: 10.1111/joic.12322. [Epub ahead of print] Review.

PMID:
27492337
6.

Transcatheter Aortic Valve Replacement: A Solution for the Young, Inoperable and Regurgitant.

Majeed K, Lucking AJ, Roberts-Thomson RL, Nelson AJ, Montarello JK, Worthley SG.

Heart Lung Circ. 2016 Oct;25(10):e126-9. doi: 10.1016/j.hlc.2016.03.013. Epub 2016 May 11.

PMID:
27265643
7.

Characterisation of Myocardial Injury via T1 Mapping in Early Reperfused Myocardial Infarction and its Relationship with Global and Regional Diastolic Dysfunction.

Azarisman SM, Carbone A, Shirazi M, Bradley J, Teo KS, Worthley MI, Worthley SG.

Heart Lung Circ. 2016 Apr 30. pii: S1443-9506(16)30070-1. doi: 10.1016/j.hlc.2016.03.011. [Epub ahead of print]

PMID:
27210302
8.

Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach.

Tzikas A, Gafoor S, Meerkin D, Freixa X, Cruz-Gonzalez I, Lewalter T, Saw J, Berti S, Nielsen-Kudsk JE, Ibrahim R, Lakkireddy D, Paul V, Arzamendi D, Nietlispach F, Worthley SG, Hildick-Smith D, Thambo JB, Tondo C, Aminian A, Kalarus Z, Schmidt B, Sondergaard L, Kefer J, Meier B, Park JW, Sievert H, Omran H.

EuroIntervention. 2016 Apr 20;11(13):1512-21. doi: 10.4244/EIJV11I13A292.

9.

Renal denervation in hypertensive patients not on blood pressure lowering drugs.

De Jager RL, Sanders MF, Bots ML, Lobo MD, Ewen S, Beeftink MM, Böhm M, Daemen J, Dörr O, Hering D, Mahfoud F, Nef H, Ott C, Saxena M, Schmieder RE, Schlaich MP, Spiering W, Tonino PA, Verloop WL, Vink EE, Vonken EJ, Voskuil M, Worthley SG, Blankestijn PJ.

Clin Res Cardiol. 2016 Sep;105(9):755-62. doi: 10.1007/s00392-016-0984-y. Epub 2016 Apr 22.

10.

1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.

Meredith IT, Walters DL, Dumonteil N, Worthley SG, Tchétché D, Manoharan G, Blackman DJ, Rioufol G, Hildick-Smith D, Whitbourn RJ, Lefèvre T, Lange R, Müller R, Redwood S, Feldman TE, Allocco DJ, Dawkins KD.

JACC Cardiovasc Interv. 2016 Feb 22;9(4):376-84. doi: 10.1016/j.jcin.2015.10.024.

11.

Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study.

Worthley S, Hendriks R, Worthley M, Whelan A, Walters DL, Whitbourn R, Meredith I.

Cardiovasc Revasc Med. 2015 Oct-Nov;16(7):413-7. doi: 10.1016/j.carrev.2015.07.009. Epub 2015 Aug 10.

12.

Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.

Tsioufis CP, Papademetriou V, Dimitriadis KS, Kasiakogias A, Tsiachris D, Worthley MI, Sinhal AR, Chew DP, Meredith IT, Malaiapan Y, Thomopoulos C, Kallikazaros I, Tousoulis D, Worthley SG.

Int J Cardiol. 2015 Dec 15;201:345-50. doi: 10.1016/j.ijcard.2015.08.069. Epub 2015 Aug 7.

PMID:
26301677
13.

Regarding "Severe bilateral renal artery stenosis after transluminal radiofrequency ablation of renal sympathetic nerve plexus".

Worthley SG, Tsioufis CP, Papademetriou V.

J Vasc Surg. 2015 Aug;62(2):539. doi: 10.1016/j.jvs.2014.02.047. No abstract available.

PMID:
26211385
14.

4A.09: SAFETY AND PERFORMANCE OF THE ENLIGHTN RENAL DENERVATION SYSTEM IN PATIENTS WITH SEVERE UNCONTROLLED HYPERTENSION: 12 MONTH RESULTS FROM THE ENLIGHTN II STUDY.

Lobo M, Saxena M, Jain AJ, Walters D, Pincus M, Montarello J, Worthley SG.

J Hypertens. 2015 Jun;33 Suppl 1:e51. doi: 10.1097/01.hjh.0000467483.82320.f7.

PMID:
26102845
15.

4A.03: CATHETER-BASED RENAL DENERVATION FOR RESISTANT HYPERTENSION: 24 MONTH RESULTS OF THE ENLIGHTN I STUDY USING A MULTIELECTRODE ABLATION SYSTEM.

Tsioufis C, Papademetriou V, Dimitriadis K, Kasiakogias A, Kordalis A, Thomopoulos C, Tsiachris D, Tousoulis D, Worthley S.

J Hypertens. 2015 Jun;33 Suppl 1:e49-50. doi: 10.1097/01.hjh.0000467477.44202.16.

PMID:
26102836
16.

8B.03: ATHEROMA PROGRESSION IN RENAL ARTERIES AFTER CATHETER-BASED RENAL ARTERY DENERVATION USING SERIAL VOLUMETRIC COMPUTED TOMOGRAPHY ANALYSIS: ANALYSIS FROM THE ENLIGHTN 1 TRIAL.

Worthley S, Kataoka Y, Nicholls S, Sidharta S, Worthley M, Tsioufis C, Papademetriou V.

J Hypertens. 2015 Jun;33 Suppl 1:e107-8. doi: 10.1097/01.hjh.0000467639.62494.f8.

PMID:
26102669
17.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.

18.

One-year clinical outcomes after sirolimus-eluting coronary stent implantation in diabetics enrolled in the worldwide e-SELECT registry.

Bartorelli AL, Egidy Assenza G, Abizaid A, Banning A, Džavík V, Ellis S, Gao R, Holmes D, Ho Jeong M, Legrand V, Neumann FJ, Spaulding C, Worthley SG, Urban P; e-SELECT Investigators.

Catheter Cardiovasc Interv. 2016 Jan 1;87(1):52-62. doi: 10.1002/ccd.26026. Epub 2015 May 27.

PMID:
26012537
19.

Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation.

Abed HS, Nelson AJ, Richardson JD, Worthley SG, Vincent A, Wittert GA, Leong DP.

Am Heart J. 2015 May;169(5):655-662.e2. doi: 10.1016/j.ahj.2015.02.008. Epub 2015 Feb 21.

PMID:
25965713
20.

Interleukin-3 greatly expands non-adherent endothelial forming cells with pro-angiogenic properties.

Moldenhauer LM, Cockshell MP, Frost L, Parham KA, Tvorogov D, Tan LY, Ebert LM, Tooley K, Worthley S, Lopez AF, Bonder CS.

Stem Cell Res. 2015 May;14(3):380-95. doi: 10.1016/j.scr.2015.04.002. Epub 2015 Apr 9.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk